View More Recent Stories
-
Notable Mergers and Acquisitions of the Day 11/05: (OTEX) (ENDP) (SLW) (AFAM)
-
Pre-Open Stock Movers 11/05: (CYTX) (ENDP) (GTAT) Higher; (BSFT) (IMGN) (LF) Lower (more...)
-
Griffin's Blue Ridge Enters Avis (CAR), LinkedIn (LNKD); Ups Citi (C), Cuts Gilead (GILD) (more...)
-
Notable Analyst Rating Changes 08/08: (GRPN) (MSFT) (LOW) Upgraded; (FIO) (HTA) (TGT) Downgraded
-
Citi Starts Endo Health (ENDP) at Buy
-
Notable Analyst Rating Changes 08/07: (MJN) (YUM) (BPI) Upgraded; (ANV) (CHRW) (DVA) Downgraded
-
Notable Analyst Rating Changes 07/24: (FTI) (AAPL) (ST) Upgraded; (BRCM) (SRPT) (PLCM) Downgraded
-
Notable 50-Day SMA Crossers 05/29: (HL) (ENDP) (JNPR) Above; (MDLZ) (ASCA) (WMT) Below
-
Lee Ainslie's Maverick Capital Shows New Stakes in (EMC) (FB)
-
Notable 52-Week Highs and Lows of the Day 01/04: (ZQK) (C) (KKD) High; (ENDP) (SVM) Low
-
Notable Analyst Rating Changes 01/04: (JNJ) (ZQK) (AVP) Upgraded; (LULU) (MSFT) (ABT) Downgraded
-
Notable Analyst Rating Changes 12/14: (HST) (MRO) (WBMD) Upgraded; (CME) (XOM) (CLWR) Downgraded
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Citi Adds Endo Pharma (ENDP) to 'Top Picks Live' List
-
Notable Analyst Rating Changes 09/29: CPE, ENDP, SCS, SPIL Upgraded; AZN, JCG, AMGN, WBSN Downgraded
-
Citi Upgrades Endo Pharmaceuticals (ENDP) to Buy
-
Notable Analyst Rating Changes 09/23: EW, MYL, NVDA, ENDP Upgraded; DYN, MO, OXPS, CVVT Downgraded
-
Notable 52-Week High's and Low's of the Day 08/18: POT, ENDP, NANO High; APP, IIN, RRC Low
-
Citi Maintains a 'Hold' Rating on Endo Pharmaceuticals (ENDP); Penwest Acquisition Makes Strategic & Financial Sense
-
Citi Resumes Coverage on Endo Pharmaceuticals Holdings (ENDP) with a Hold
-
Citi reiterates a 'Hold' on Endo Pharmaceuticals (ENDP); 1Q10 Preview: Opana Franchise Contributing to Outperformance
-
Shares of Endo Pharma (ENDP) Tumbling as Citi Downgrades Intraday
-
Notable Analyst Ratings Changes 12/08: UAUA, CBS, STP, JASO, AGU, SYY Upgraded; S, ENDP, CCJ, BEAV Downgraded
-
Citi Maintains a 'Buy' on Endo Pharmaceuticals (ENDP); Lowers Price Target
-
Citi Initiates Coverage on Endo Pharmaceuticals (ENDP) with a Buy

